DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

DBV Technologies S.A. (EPA:DBV) just released its latest annual results and things are looking bullish. Revenue crushed expectations at US$16m, beating expectations by 83%. DBV Technologies reported a statutory loss of US$0.77 per share, which - although not amazing - was much smaller than the analysts predicted. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

View our latest analysis for DBV Technologies

Following the recent earnings report, the consensus from three analysts covering DBV Technologies is for revenues of US$8.16m in 2024. This implies a concerning 48% decline in revenue compared to the last 12 months. Per-share losses are supposed to see a sharp uptick, reaching US$0.85. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$8.22m and losses of US$0.86 per share in 2024.

As a result, it's unexpected to see that the consensus price target fell 11% to €4.43, with the analysts seemingly becoming more concerned about ongoing losses, despite making no major changes to their forecasts. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values DBV Technologies at €9.00 per share, while the most bearish prices it at €1.90. As you can see the range of estimates is wide, with the lowest valuation coming in at less than half the most bullish estimate, suggesting there are some strongly diverging views on how analysts think this business will perform. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. One more thing stood out to us about these estimates, and it's the idea that DBV Technologies' decline is expected to accelerate, with revenues forecast to fall at an annualised rate of 48% to the end of 2024. This tops off a historical decline of 18% a year over the past five years. Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to grow 37% annually. So while a broad number of companies are forecast to grow, unfortunately DBV Technologies is expected to see its revenue affected worse than other companies in the industry.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of DBV Technologies' future valuation.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple DBV Technologies analysts - going out to 2026, and you can see them free on our platform here.

However, before you get too enthused, we've discovered 3 warning signs for DBV Technologies (1 doesn't sit too well with us!) that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.